The latest news and insights from the Pricing, Market Access and Pharmaceutical space:
- NICE joins international consortium aimed at improving clinical decision making for lung cancer patients
- EMA phases out extraordinary COVID-19 regulatory flexibilities
- Endometrial cancer patients gain early access to GSK’s Jemperli
- The wait times for new medications in France are on the rise